10 Common Fears About HIV Transmission

We've received tens of thousands of questions from people agonizing over HIV exposure. Uncertainty can be terrifying -- but many common fears don’t pose HIV risk.

Featured

Several HIV Vaccine Research Trials Are in the Works. Here's What You Should Know.

HIV Vaccine Awareness Day 2019 falls on the cusp of a scientific breakthrough.

By Sony Salzman

Has Anyone Gotten HIV When They Were on PrEP?

One of the persisting fears people may have when starting PrEP is wondering whether a risk remains of contracting HIV while on PrEP without using an additional barrier method.

By Damon L. Jacobs, L.M.F.T.

Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find

But a survey reveals that about a third of black and Latino gay men would be willing to pay more than $50 per month for a prescription.

By Sony Salzman

PrEP Pricing Is the Elephant in the Room at the CDC National HIV Prevention Conference

In a debate during a plenary session, Michael Saag, M.D., argued for more activism to make PrEP accessible to people who need it.

By Sony Salzman

HIV Rapid Testing & Treatment Must Be a Priority at Fulton County Jail

Georgia HIV activist Shyronn Jones decries a recent statement from the Fulton County Sheriff's Office that it had stopped rapid HIV testing for inmates because the practice was "antiquated."

By Shyronn Jones

For HIV, Treatment is Prevention

The director of the U.S. National Institutes of Health talks about a newly published expert article explaining that sexual transmission of HIV can't happen if a person is on fully effective treatment.

By Francis Collins, M.D., Ph.D. for U.S. National Institutes of Health

Stop Blaming PrEP for the Rise in STIs -- the Picture Is More Complex Than That

"PrEP must not be cast as the lone villain in the syphilis crisis, nor MSM engaging in chemsex cast as debauched vectors of transmission."

By Oli Stevens and T Charles Witzel for The Conversation

States Innovate to Expand PrEP Availability and Uptake

As part of comprehensive efforts to reduce the number of new HIV infections, some states are innovating to make HIV pre-exposure prophylaxis (PrEP) more accessible to individuals at high risk of HIV.

By HIV.gov

The U.S. Takes a First but Long Overdue Step Toward Building a National PrEP Program

On Nov. 20, 2018, the U.S. Preventive Services Task Force released a draft recommendation that could transform HIV-1 pre-exposure prophylaxis (PrEP) scale-up in the United States.

By Christian Antonio Urrutia and James Krellenstein

AVAC at HIVR4P: How We Carry On

"Every member of the AVAC team in Madrid was moved and motivated by the Madrid conference," AVAC writes. "We know the work is not easy, nor is the world."

By AVAC: Global Advocacy for HIV Prevention